ESTEVE INCREASES NET REVENUE BY 5% AND REAFFIRMS STRATEGY TOWARDS BECOMING A HIGHLY SPECIALIZED COMPANY

By reaching €744 million and expanding its portfolio, the company moves forward in its vision of becoming a leading international pharmaceutical company BARCELONA, Spain, May 14, 2025 /PRNewswire/ -- The pharmaceutical company ESTEVE has presented its 2024 annual results report, aligned...